Table 2 Therapies during the study.
Medication | HCTZ (n = 26) | Placebo (n = 25) | p-value |
|---|---|---|---|
Endovenous furosemide (3-day total dose, mg) | 259 ± 143 | 246 ± 141 | 0.62 |
Endovenous furosemide (3-day total dose/kg, mg) | 3.25 ± 1.47 | 3.25 ± 1.83 | p = 0.997 |
Spironolactone (3-day total dose, mg) | 26 ± 31 | 28 ± 37 | 0.94 |
Norepinephrine (%) | 3.8 | 0 | 1.00 |
Sodium nitroprusside (%) | 7.7 | 4.0 | 1.00 |
Milrinone (%) | 3.8 | 0 | 1.00 |
Endovenous nitroglycerin (%) | 7.7 | 8.0 | 1.00 |
